학술논문

SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)
Document Type
Article
Source
In Clinical Lung Cancer May 2021 22(3):178-186
Subject
Language
ISSN
1525-7304